Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 627 of 6351
-
New 'Double Punch' CAR T-Cell therapy takes on tough blood cancers
Disease control Recruiting nowThis is a Phase I, prospective, dose-finding study to evaluate the safety, persistence, and clinical activity of GF-CART01 in subjects aged 18-70 with relapsed or refractory (R/R) B-cell hematological malignancies and failure of two-line or more standard chemotherapies or auto-he…
Phase 1 • Sponsor: GenomeFrontier Therapeutics TW Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
A handful of walnuts a day: could it keep the aging mind sharp?
Knowledge-focused OngoingThe purpose of this study is to examine the impact of daily consumption of walnuts for 12 weeks on cognitive function, markers of inflammation and oxidative stress, and the gut microbiome in healthy adults age 55 years and older.
Sponsor: Oregon State University • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Could a tiny dose of radiation beat lymphoma with fewer side effects?
Disease control Recruiting nowThe researchers are doing this study to find out whether a very low dose of radiation therapy (VLDRT) is an effective treatment for people with follicular lymphoma (FL) or marginal zone lymphoma (MZL) and works as well as the standard dose of radiation therapy. The researchers wi…
Phase 3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New hope for toddlers with sickle cell: drug may stop painful attacks
Prevention Recruiting nowThis post-authorisation safety and efficacy study (PRECISE PASS) evaluates the use of Xromi® (hydroxycarbamide 100 mg/mL oral solution) in children aged 9 months to under 2 years with sickle cell disease (SCD). The objective is to assess the safety profile and clinical effective…
Sponsor: Nova Laboratories Limited • Aim: Prevention
Last updated Jun 27, 2026 09:11 UTC
-
Sweat away brain fog: exercise may slow Parkinson's cognitive decline
Disease control Recruiting nowCognitive impairment is an acknowledged feature of Parkinson's disease (PD) and often coexists with the classic motor symptoms since their onset. Cognitive symptoms of PD can be differentiated from other neurodegenerative diseases by the affected domains: typically, the executive…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can better sleep ease the burden of heart failure?
Symptom relief CompletedThis study aims to evaluate the effectiveness of a structured nursing intervention incorporating sleep hygiene education and cognitive-behavioral strategies on improving sleep quality among patients with chronic heart failure. Sleep disturbances are common in patients with chroni…
Sponsor: Al-Zaytoonah University of Jordan • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Nerve block injection may tame deadly heart storms
Disease control Recruiting nowThere is no randomized clinical study in the literature that evaluated the efficacy and safety of the stellate ganglion infiltration procedure in patients with electrical storm. So far, case reports and retrospective studies suggest that such a strategy should be considered in ca…
Phase 4 • Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Activism as medicine: new study tests if fighting racism can shield youth from depression
Prevention Recruiting nowOver 15 million people participated in racial justice protests nationwide during 2020-2021 spotlighting activism as a collective tool against structural racism and discrimination (SRD). SRD manifests as policies and practices (e.g., redlining, voter suppression, mass incarceratio…
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
Balloon treatment could stop hidden heart plaques from causing attacks
Disease control OngoingThe PASSIVATE-CAP study is an investigator-initiated, prospective, randomized, multicenter, open-label superiority trial focusing on acute coronary syndrome (ACS) patients with nonflow-limiting vulnerable plaques in nonculprit vessels. In this study, eligible patients were random…
Sponsor: Yong He • Aim: Disease control
Last updated Jun 26, 2026 15:09 UTC
-
New hope for rare vasculitis: Three-Drug trial targets Non-Responders
Disease control Recruiting nowThe purpose of this study is to identify the most promising therapeutic strategy for patients with granulomatosis with polyangiitis and inadequate response to standard of care therapy. It will evaluate the efficacy to induce remission of three different salvage strategies includi…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New study aims to stop Post-Surgery confusion with sleep and brain training
Prevention Recruiting nowSleep disturbances, cognitive reserve, and continuing pain and inflammation are other risk factors contributing to delirium (confusion and agitation) and neurocognitive decline (in the long term) following heart surgery. Investigators aim to test a bundle of sleep optimization, c…
Phase 3 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
Gut bacteria may soothe menopause symptoms — a trial puts it to the test
Symptom relief CompletedFemmeBiome Meno is a synbiotic supplement, meaning it contains both probiotics (beneficial bacteria) and prebiotics (a special kind of fiber that feeds these bacteria). It is made up of: One capsule with 4 carefully selected bacterial strains and one sachet of powdered fiber. B…
Sponsor: University College Cork • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
New antibody cocktail aims to stop rabies after multiple dog bites
Prevention OngoingThe objective of this real-world, prospective observational study is to evaluate the clinical effectiveness of zamerovimab and mazorelvimab injection (a human rabies monoclonal antibody cocktail) administered in combination with a standard rabies vaccine for post-exposure prophyl…
Sponsor: Synermore Biologics (Suzhou) Co., Ltd. • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
A genetic score could sharpen breast cancer risk prediction
Prevention Recruiting nowThis single-arm interventional feasibility study will evaluate whether integrating polygenic risk scores (PRS) into the CanRisk model can improve breast cancer risk prediction and personalized prevention in women at risk of breast cancer. The study will assess the organizational …
Sponsor: Catholic University of the Sacred Heart • Aim: Prevention
Last updated Aug 05, 2026 00:00 UTC
-
Can less be more? trial tests cutting RA medication doses
Disease control Recruiting nowThis study aims to assess the feasibility of tapering JAK inhibitors in rheumatoid arthritis patients in low disease activity by comparing a group of patients tapering the JAK inhibitor dosage to a group of patients continuing the full-dose. Participants will: * Either take …
Phase 4 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
What happens to elite Athletes' health after retirement?
Knowledge-focused By invitation onlyThe health of former elite athletes has been identified as a critical research gap where there is limited knowledge about both short- and long-term consequences after ending their careers. The transition phase from an active elite career to everyday life has been shown to be part…
Sponsor: Norwegian School of Sport Sciences • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
New hope for cancer patients: drug may replace opioids for mouth sore pain
Symptom relief Recruiting nowThis phase III trial tests if gabapentin can prevent the need for opiate pain medication for mouth sores (oral mucositis) in patients undergoing treatment with chemotherapy and radiation for squamous cell carcinoma of the head and neck region. Oral mucositis is a common side effe…
Phase 3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
New drug may reduce blood transfusions for anemia patients
Disease control Recruiting nowThe goal of this clinical trial is to determine if momelotinib is safe and effective for people with low-risk myelodysplastic syndromes (LR-MDS). The trial will also examine how the body processes the drug. Participants will receive different doses of momelotinib to find the best…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a common spice boost liver health in fatty liver disease?
Disease control CompletedThis randomized controlled trial aims to evaluate the effects of Rhus coriaria L. (Sumac) supplementation combined with a calorie-restricted diet on hepatic function and metabolic health in grade-I obese patients with non-alcoholic fatty liver disease (NAFLD). A total of 102 part…
Sponsor: University of Lahore • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New drug offers hope for lymphoma patients who Can't get transplants
Disease control Recruiting nowThe purpose of this study is to measure the efficacy of the study drug, epcoritamab, in participants with relapsed/refractory large B-cell lymphoma.
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC